The negative symptoms of schizophrenia are notoriously difficult to address with traditional treatments. The meta-analysis suggests TMS can significantly improve negative symptoms and may offer a promising new treatment approach.

This comprehensive study highlights the need for gender-specific treatment in schizophrenia spectrum disorders, revealing that hormonal changes call for lower antipsychotic doses for female patients under 45 and higher doses for those who are post-menopausal.